DEXCOM INC (1DXCM.MI) Stock Fundamental Analysis
Europe - BIT:1DXCM - US2521311074 - Common Stock
60.83 EUR
+5.32 (+9.58%)
1DXCM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 62 industry peers in the Health Care Equipment & Supplies industry. While 1DXCM belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1DXCM is valued quite expensively, but it does show have an excellent growth rating. This makes 1DXCM very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year 1DXCM was profitable.
1DXCM had a positive operating cash flow in the past year.
Each year in the past 5 years 1DXCM has been profitable.
1DXCM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.80%, 1DXCM is in the better half of the industry, outperforming 79.37% of the companies in the same industry.
1DXCM has a better Return On Equity (22.21%) than 88.89% of its industry peers.
1DXCM has a better Return On Invested Capital (14.52%) than 92.06% of its industry peers.
1DXCM had an Average Return On Invested Capital over the past 3 years of 11.25%. This is above the industry average of 8.76%.
The last Return On Invested Capital (14.52%) for 1DXCM is above the 3 year average (11.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| ROIC | 14.52% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
1DXCM has a Profit Margin of 13.29%. This is in the better half of the industry: 1DXCM outperforms 74.60% of its industry peers.
In the last couple of years the Profit Margin of 1DXCM has grown nicely.
With a decent Operating Margin value of 17.22%, 1DXCM is doing good in the industry, outperforming 74.60% of the companies in the same industry.
1DXCM's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 60.01%, 1DXCM perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
1DXCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.22% | ||
| PM (TTM) | 13.29% | ||
| GM | 60.01% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1DXCM is creating value.
Compared to 1 year ago, 1DXCM has more shares outstanding
The number of shares outstanding for 1DXCM has been increased compared to 5 years ago.
The debt/assets ratio for 1DXCM has been reduced compared to a year ago.
2.2 Solvency
1DXCM has an Altman-Z score of 5.00. This indicates that 1DXCM is financially healthy and has little risk of bankruptcy at the moment.
1DXCM's Altman-Z score of 5.00 is amongst the best of the industry. 1DXCM outperforms 80.95% of its industry peers.
The Debt to FCF ratio of 1DXCM is 4.38, which is a neutral value as it means it would take 1DXCM, 4.38 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1DXCM (4.38) is better than 60.32% of its industry peers.
1DXCM has a Debt/Equity ratio of 0.50. This is a neutral value indicating 1DXCM is somewhat dependend on debt financing.
1DXCM has a Debt to Equity ratio of 0.50. This is comparable to the rest of the industry: 1DXCM outperforms 41.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.38 | ||
| Altman-Z | 5 |
ROIC/WACC1.85
WACC7.86%
2.3 Liquidity
1DXCM has a Current Ratio of 1.52. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1DXCM (1.52) is comparable to the rest of the industry.
1DXCM has a Quick Ratio of 1.35. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of 1DXCM (1.35) is better than 68.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
The earnings per share for 1DXCM have decreased by -2.86% in the last year.
1DXCM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.25% yearly.
1DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.30%.
1DXCM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.27% yearly.
EPS 1Y (TTM)-2.86%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%11.63%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%15.21%
3.2 Future
Based on estimates for the next years, 1DXCM will show a very strong growth in Earnings Per Share. The EPS will grow by 22.60% on average per year.
The Revenue is expected to grow by 13.90% on average over the next years. This is quite good.
EPS Next Y26.84%
EPS Next 2Y26.2%
EPS Next 3Y24.65%
EPS Next 5Y22.6%
Revenue Next Year14.99%
Revenue Next 2Y15.17%
Revenue Next 3Y14.81%
Revenue Next 5Y13.9%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 41.66, the valuation of 1DXCM can be described as expensive.
1DXCM's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.89. 1DXCM is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 27.04 indicates a quite expensive valuation of 1DXCM.
1DXCM's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of 1DXCM to the average of the S&P500 Index (22.99), we can say 1DXCM is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.66 | ||
| Fwd PE | 27.04 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1DXCM.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1DXCM is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.82 | ||
| EV/EBITDA | 25.67 |
4.3 Compensation for Growth
1DXCM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1DXCM has an outstanding profitability rating, which may justify a higher PE ratio.
1DXCM's earnings are expected to grow with 24.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.55
PEG (5Y)1.42
EPS Next 2Y26.2%
EPS Next 3Y24.65%
5. Dividend
5.1 Amount
No dividends for 1DXCM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1DXCM (10/23/2025, 7:00:00 PM)
60.83
+5.32 (+9.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.73%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap23.86B
Revenue(TTM)4.30B
Net Income(TTM)571.50M
Analysts84.57
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.34%
Min EPS beat(2)-4.09%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-1.87%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)9.43%
EPS beat(12)10
Avg EPS beat(12)14.38%
EPS beat(16)11
Avg EPS beat(16)8.49%
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-0.19%
Max Revenue beat(2)0.88%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.78%
Revenue beat(12)5
Avg Revenue beat(12)-0.39%
Revenue beat(16)6
Avg Revenue beat(16)-0.42%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0.42%
EPS NQ rev (3m)0.62%
EPS NY rev (1m)0.14%
EPS NY rev (3m)1.25%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.75%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.66 | ||
| Fwd PE | 27.04 | ||
| P/S | 6.48 | ||
| P/FCF | 48.82 | ||
| P/OCF | 28.21 | ||
| P/B | 10.83 | ||
| P/tB | 11.32 | ||
| EV/EBITDA | 25.67 |
EPS(TTM)1.46
EY2.4%
EPS(NY)2.25
Fwd EY3.7%
FCF(TTM)1.25
FCFY2.05%
OCF(TTM)2.16
OCFY3.54%
SpS9.39
BVpS5.62
TBVpS5.37
PEG (NY)1.55
PEG (5Y)1.42
Graham Number13.58
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| ROCE | 18.43% | ||
| ROIC | 14.52% | ||
| ROICexc | 53.56% | ||
| ROICexgc | 59.66% | ||
| OM | 17.22% | ||
| PM (TTM) | 13.29% | ||
| GM | 60.01% | ||
| FCFM | 13.27% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score6
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.38 | ||
| Debt/EBITDA | 1.33 | ||
| Cap/Depr | 176.58% | ||
| Cap/Sales | 9.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.12% | ||
| Profit Quality | 99.88% | ||
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 5 |
F-Score6
WACC7.86%
ROIC/WACC1.85
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.86%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%11.63%
EPS Next Y26.84%
EPS Next 2Y26.2%
EPS Next 3Y24.65%
EPS Next 5Y22.6%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%15.21%
Revenue Next Year14.99%
Revenue Next 2Y15.17%
Revenue Next 3Y14.81%
Revenue Next 5Y13.9%
EBIT growth 1Y6.1%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year77.25%
EBIT Next 3Y38.83%
EBIT Next 5Y31.4%
FCF growth 1Y22.49%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y28.04%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / 1DXCM.MI FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 6 / 10 to 1DXCM.MI.
What is the valuation status for 1DXCM stock?
ChartMill assigns a valuation rating of 3 / 10 to DEXCOM INC (1DXCM.MI). This can be considered as Overvalued.
What is the profitability of 1DXCM stock?
DEXCOM INC (1DXCM.MI) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for 1DXCM stock?
The Price/Earnings (PE) ratio for DEXCOM INC (1DXCM.MI) is 41.66 and the Price/Book (PB) ratio is 10.83.
What is the expected EPS growth for DEXCOM INC (1DXCM.MI) stock?
The Earnings per Share (EPS) of DEXCOM INC (1DXCM.MI) is expected to grow by 26.84% in the next year.